Bottom line
MYCO vs XLV: the short answer
MYCO (SPDR SSGA My2035 Corporate Bond ETF) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both etfs.
XLV is cheaper at 0.08% vs 0.15% — a difference of $7.00 a year per $10,000 invested.
Updated Nov 19, 2026
MYCO vs XLV side by side
| MYCO | XLV | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | SPDR (State Street) | SPDR (State Street) |
| Category | Corporate Bond | Health Care Sector |
| Expense ratio | 0.15% | 0.08% |
| Annual cost per $10k | $15 | $8 |
| 10-yr cost on $10k (prospectus) | — | $103 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0.02% |
| 1-yr return | — | +14.5% |
| 5-yr return (annualized) | — | +8.1% |
| 10-yr return (annualized) | — | +9.8% |
| Best quarter | — | +14.5% |
| Worst quarter | — | −12.7% |
| Net assets (fund) | $6.1M | $40.6B |
| Number of holdings | 94 | 65 |
| Portfolio turnover | — | 2% |
| Returns as of | — | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
MYCO and XLV share none of their top holdings.
MYCO top 10
- Charter Comm Opt Llc/cap — 2.21%
- Abbvie Inc — 2.20%
- Rtx Corp — 2.19%
- Pacific Gas & Electric — 2.18%
- Jbs Nv/USA Foods/food Co — 2.12%
- Aep Transmission Co Llc — 2.09%
- Georgia Power Co — 2.08%
- At&t Inc — 2.08%
- Ibm Corp — 2.07%
- Firstenergy Transmission — 2.03%
XLV top 10
- Eli Lilly & Co — 16.51%
- Johnson & Johnson — 10.64%
- AbbVie Inc — 7.74%
- UnitedHealth Group Inc — 6.57%
- Merck & Co Inc — 5.52%
- Amgen Inc — 3.40%
- Thermo Fisher Scientific Inc — 3.24%
- Abbott Laboratories — 2.75%
- Gilead Sciences Inc — 2.73%
- Intuitive Surgical Inc — 2.45%
FAQ
What is the difference between MYCO and XLV?
MYCO (SPDR SSGA My2035 Corporate Bond ETF) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both etfs. XLV is cheaper at 0.08% vs 0.15% — a difference of $7.00 a year per $10,000 invested.
Which is cheaper, MYCO or XLV?
XLV has the lower expense ratio (0.08%).
Should I own both MYCO and XLV?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.